Unique ID issued by UMIN | UMIN000023758 |
---|---|
Receipt number | R000027005 |
Scientific Title | Evaluation of safety and effectiveness of the Microwave Surgical Device (Acrosurg.TM) in surgical procedures. |
Date of disclosure of the study information | 2016/08/25 |
Last modified on | 2016/09/08 14:10:07 |
Evaluation of safety and effectiveness of the Microwave Surgical Device (Acrosurg.TM) in surgical procedures.
Evaluation of safety and effectiveness of the Microwave Surgical Device in surgical procedures.
Evaluation of safety and effectiveness of the Microwave Surgical Device (Acrosurg.TM) in surgical procedures.
Evaluation of safety and effectiveness of the Microwave Surgical Device in surgical procedures.
Japan |
Disease for Digestive surgery (esophagus, stomach, colorectum, pancreas, liver and hernia) and Breast surgery.
Surgery in general | Gastrointestinal surgery | Hepato-biliary-pancreatic surgery |
Breast surgery |
Malignancy
NO
Evaluation of safety and effectiveness of the Microwave Surgical Device (Acrosurg.TM) in digestive surgery (esophagus, stomach, colorectum, pancreas, liver and hernia) and breast surgery.
Safety,Efficacy
Hemorrhagic adverse events during and after surgery
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
Using Microwave Surgical Device (Acrosurg.TM) in digestive surgery (esophagus, stomach, colorectum, pancreas, liver and hernia) and breast surgery instead of the ordinary energy devices.
20 | years-old | <= |
Not applicable |
Male and Female
1) PS (ECOG Performance Status Scale):0-1
2) BMI (body mass index) <=30
3) Patients who have no severe disorder of blood coagulation and organ failure.
4) Patients in case that the person or legal representative can provide written informed consent.
1) Patients with serious concomitant diseases such as ischemic heart disease or arrhythmia to need treatment, myocardial infarction developed within 6 months, liver failure, diabetes having poor control or bleeding tendency.
2) Patients with infectious disease or patients who is possibly infected having fever.
3) Patients who have the following examination data.
1. WBC<3,000/mm3
2. Plt. <50,000/mm3
3. AST >100 IU/L, ALT>100IU/L
4. T-Bil >3.0 g/dl
5. CRE >2.0 mg/dl
40
1st name | |
Middle name | |
Last name | Shigeyuki Naka |
Shiga University of Medical Science
Department of gastrointestinal Surgery, Breast and General Surgery
eta-Tsukinowa-cho, Otsu, Shiga, Japan
077-548-2238
naka@belle.shiga-med.ac.jp
1st name | |
Middle name | |
Last name | Shigeyuki Naka |
Shiga University of Medical Science
Department of gastrointestinal Surgery, Breast and General Surgery
eta-Tsukinowa-cho, Otsu, Shiga, Japan
077-548-2238
naka@belle.shiga-med.ac.jp
Shiga University of Medical Science
Department of Surgery
NIKKISO CO., LTD.
Profit organization
NO
2016 | Year | 08 | Month | 25 | Day |
Unpublished
Preinitiation
2016 | Year | 08 | Month | 01 | Day |
2016 | Year | 08 | Month | 25 | Day |
2016 | Year | 08 | Month | 25 | Day |
2016 | Year | 09 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027005